Accordingly, lung cancer cell lines (like NCI-H1581 and NCI-H520 cells) have been identified that harbor amplification of FGFR1 and are highly sensitive to FGFR inhibitors in vitro and in vivo [18,19]. This evidence concerns the gene FGFR1 and lung carcinoma.